Risk-based monitoring (RBM) is an evolving concept in the clinical trial industry that is transforming the ways trials are done. So what is risk-based monitoring? We had a chance to speak with Andy ...

Before the onset of the coronavirus pandemic, leading organizations in clinical research had been gradually discovering, experimenting with, and implementing remote technology. The pandemic has ...

Technology has enabled clinical medicine to adapt remarkably during the COVID-19 pandemic. Through virtual clinic visits, telehealth has allowed clinicians to evaluate and treat patients while ...

The Immune Monitoring shared resource supports investigators seeking precise evaluations of immunologic responses in both basic and early-stage clinical research settings. We provide users with ...

Icon has reached a preliminary agreement with Intel to use the Intel Pharma Analytics Platform in clinical trials. Launched in 2013, the Intel platform can continuously monitor and collect clinical ...

In a recent study posted to the medRxiv* preprint server, researchers in the United Kingdom described key measurements for monitoring clinical activity during the coronavirus disease 2019 (COVID-19) ...

Clinical trials, often one of the most expensive parts of bringing a drug to market, can last as long as a decade. The Covid-19 pandemic has proven clinical trials can be successfully completed in ...